Korea’s Global Clinical Trial Magnetism

Add bookmark

The rising presence of clinical trials (CT) in the Asia-Pacific region is predominantly driven by the East Asian region which includes China, Japan, Korea, Taiwan and Hong Kong. Over the past decade, Korea has become a global clinical trial hub and is one of the leading clinical trial destinations in the Asian region; with approximately 80% of its CTs being multinational trials from 2001-2012.The support of entities such as Korea National Enterprise for Clinical Trials (KoNECT), which was establ...
To continue reading this story get free access

RECOMMENDED